CH8600/CRP Automatic Hematology Analyzer

CH8600/CRP Automatic Hematology Analyzer

Cell Counters

Information

1. Wide Linear Range: Innovative multiploidy algorithm ensures accurate results for WBC (0.00-520)×10⁹/L and RBC (0.00-8.70)×10¹²/L. 2. Ample Data Storage: Large built-in storage capacity for seamless data management. STAT Sample Priority: Emergency samples can be inserted immediately for rapid turnaround. 3. Real-Time Reagent Monitoring: Reagent levels are tracked and displayed in real time. 4. One-Touch Mode Switching: Effortlessly change detection modes for operational flexibility. 5. Space-Saving Design: Compact, innovative industrial design optimizes lab space.
Shenzhen CoooSeee Biomedical Co., Ltd.H3.A30CoooSeee Biomedical, a subsidiary of Comen Group, specializes in the in vitro diagnostics (IVD) field. We are committed to providing global users with high-performance IVD medical instruments and consumables. Our products, including hematology analyzers, specific protein analyzers, hematology automation line, demonstrating strong technological competitiveness and strengthening our industry position in the in-vitro diagnostics market. Beyond existing business domains, we continue to intensify R&D investment and technological innovation in biochemistry, chemiluminescence,and coagulation testing, delivering comprehensive integrated laboratory solutions globally. Comen Group, a clinician-focused R&D enterprise headquartered in Shenzhen, has continually advanced in life supporting systems, medical imaging and healthcare informatics since its founding in 2002, while expanding into IVD and surgical solutions. With 40+ global subsidiaries, we serve 270,000 hospitals and medical institutions across 190+ countries and regions. Leveraging Comen Group's mature R&D infrastructure and production expertise in medical devices, CoooSeee Biomedical integrates product development, manufacturing, market services and corporate management resources to accelerate our evolution into a world-class medical device enterprise. Furthermore, Comen Group s 20+ years of accumulated user and channel partnerships will serve as strategic assets for CoooSeee Biomedical, collectively advancing the global healthcare ecosystem.

Log in

See all the content and easy-to-use features by logging in or registering!